Ki sa "Klè" vle di?
Bèt la pa pote mitasyon an. Li pa pral devlope maladi a epi yo pa pral pase li sou.
Chen Dejenerasyon sistèm miltip chen nan Kerry Blue Terrier (CMSD-KBT)
The Canine Multiple System Degeneration (CMSD) DNA test is essential for Kerry Blue Terrier owners to ensure their dogs' health. CMSD is a hereditary neurological disorder affecting coordination and movement in Kerry Blue Terriers. Early genetic testing helps identify carriers and affected dogs, enabling responsible breeding decisions. By using the CMSD DNA test, breeders can reduce the risk of passing this debilitating condition to future generations. This test provides accurate, reliable results, promoting the well-being of your Kerry Blue Terrier. Protect your dog’s health with the CMSD DNA test today. Regular screening supports a healthier, happier canine companion.
Abreviyasyon: CMSD-KBT
Analize mitasyon: SERAC1 c.1536G>A
Eritaj: Otozomal resesif
Akwonim
CMSD-KBT
Obsève frekans
Gravite nan klinik
Klasifikasyon klinik
Maladi newolojik
Analize mitasyon
SERAC1 c.1536G>A
p.(Trp512*)
p.(Trp512*)
Mòd eritaj
Otozomal resesif
Rezime tès la:
Canine Multiple System Degeneration (CMSD) is a genetic disorder affecting Kerry Blue Terriers, causing progressive neurological decline. A DNA test is available to identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing can prevent the spread of this debilitating condition within the breed. Responsible breeding practices rely on these genetic insights to maintain healthy Kerry Blue Terrier populations. Overall, the CMSD DNA test is a valuable tool for canine health management.
Disponib nan pake a: Basic
Tès ADN sa a enkli apati pake nou an Basic — epi tou se yon pati nan pake yo Basic, Standard, Advanced, Complete.
Gade pake tès ADN →Chwazi pake ki pi byen adapte elvaj ou oswa estrateji sante bèt ou yo.
Understanding Canine Multiple System Degeneration in Kerry Blue Terriers (CMSD-KBT)
Canine Multiple System Degeneration (CMSD) is a progressive neurological disorder that primarily affects Kerry Blue Terriers. This condition is characterized by the degeneration of multiple systems within the nervous system, leading to a range of debilitating symptoms that can significantly impact the quality of life of affected dogs.
Symptoms of CMSD-KBT
The symptoms of CMSD-KBT typically manifest in early to mid-adulthood, although the age of onset can vary. Common signs include balance problems, difficulty walking, and a general lack of coordination. As the disease progresses, affected dogs may exhibit muscle weakness, tremors, and a decline in overall mobility. In some cases, dogs may also experience changes in behavior, such as increased anxiety or a reluctance to engage in normal activities.
Pathophysiology of CMSD-KBT
The underlying cause of CMSD-KBT lies in genetic mutations that affect the nervous system's ability to function properly. These mutations lead to the degeneration of nerve cells, which in turn causes a breakdown of communication between the brain and the body. This disruption results in the clinical symptoms observed in affected dogs. Understanding the genetic basis of CMSD-KBT is crucial for breeders and owners, as it allows for informed decisions regarding breeding practices and the management of affected animals.
Jesyon ak swen pou chen ki afekte yo
While there is currently no cure for CMSD-KBT, management strategies can help improve the quality of life for affected dogs. Regular veterinary check-ups are essential for monitoring the progression of the disease and addressing any health concerns that arise. Physical therapy and rehabilitation exercises can assist in maintaining mobility and strength. Additionally, providing a safe and supportive environment can help dogs cope with their symptoms and enhance their overall well-being.
Konklizyon
Canine Multiple System Degeneration in Kerry Blue Terriers is a serious condition that requires attention from dog owners and breeders. By understanding the symptoms, underlying causes, and management strategies associated with CMSD-KBT, stakeholders can work towards improving the lives of affected dogs while making informed breeding decisions to reduce the prevalence of this condition in the breed.
Race rekonèt pou tès la: Dejenerasyon sistèm miltip chen nan Kerry Blue Terrier (CMSD-KBT)
- Kerry Blue Terrier
🧬 Interpretation of genotypes CMSD-KBT
Jenotip
Estati
🟡 N/N
Ki pa konpayi asirans - Pa gen risk
🟡 N/CMSD-KBT
Konpayi asirans - Pa gen risk
❌ CMSD-KBT/CMSD-KBT
Afekte - Nan Risk
FAQ: konprann entèpretasyon an
Èske yon "Carrier" serye?
Non. Bèt la jeneralman an sante men li ka transmèt mitasyon an bay li pitit pitit.
E si yon bèt "Afekte"?
Li pote de kopi mitasyon. Siy klinik yo espere depann sou maladi a. Li pa ta dwe elve.
Poukisa gen diferans ant gason / fi?
Gen kèk maladi ki lye ak sèks, kidonk ekspresyon yo varye selon la sèks bèt.
Predi pitit pitit
N/N (ki-pa-transpote)
N/CMSD-KBT (Carrier)
CMSD-KBT/CMSD-KBT (Afekte)
FAQ Tès ADN
Kisa tès ADN sa a detekte?
This DNA test detects the mutation associated with Canine Multiple System Degeneration In Kerry Blue Terrier (CMSD-KBT) in order to identify clear, carrier, or at-risk animals.
Poukisa teste yon bèt elvaj?
Tès ADN ede elve yo planifye kwazman ki pi an sekirite epi redwi risk pou yo transmèt mitasyon an bay pitit pitit yo.
Ki mòd eritaj tès sa a?
Mòd eritaj ki rapòte pou tès sa a se otozomal resesif.
Ki mitasyon ki analize nan tès sa a?
This test analyses the mutation SERAC1 c.1536G>A.
Èske yon bèt transporteur nesesèman afekte?
Pa nesesèman. Entèpretasyon depann sou modèl eritaj la ak jenotip ki kapab lakòz.
Referans
Johnson GS, Mhlanga-Mutangadura T, Morava E, Kozicz T, Taylor JF, O’Brien DP, Schnabel RD. Canine Multiple System Degeneration is Associated with Distinct SERAC1 Mutations in Two Different Dog Breeds [abstract]. Presented at the 63rd Annual Meeting of the American Society of Human Genetics in Boston, Massachusetts; 2013 Oct 22-26.